Get started
Author

Ninggang Zhang

Tumor-Associated Macrophage-Derived Exosomes Promote Progression of Gastric Cancer by Regulating P38MAPK Signaling Pathway and Immune Checkpoint PD-L1
2021 · Yusheng Wang, Kun Shang, et al. · Cancer Biotherapy and Radiopharmaceuticals · 27
LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition
2020 · Ninggang Zhang, Yaqiong Ren, et al. · Journal of Cancer · 26
PDF
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
2019 · Jian Zhao, Junmei Lei, et al. · Investigational New Drugs · 22
PDF
Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib
2019 · Zhengxing Gao, Chunqing Song, et al. · OncoTargets and Therapy · 19
PDF
Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib
2020 · Xiangyao Lian, Cuimin Zhu, et al. · Bioscience Reports · 11
PDF
Injectable anticancer biodegradable hydrogel-based nanocomposites: Synergistic pH-responsive paclitaxel/β-cyclodextrin nanocomplex delivery in polyvinyl alcohol hydrogel for targeted pancreatic ductal adenocarcinoma treatment
2025 · Xiuxiu Li, Weiyu Ma, et al. · International Journal of Pharmaceutics · 8
Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor
2022 · Ninggang Zhang, Yaqiong Ren, et al. · Frontiers in Oncology · 8
PDF
Efficacy and safety of sintilimab-based regimens against advanced gastric and gastroesophageal junction adenocarcinoma
2021 · Yusheng Wang, Jian Zhao, et al. · Journal of Cancer Research and Therapeutics · 7
A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) in gastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in progress.
2025 · Lin Shen, Kohei Shitara, et al. · Journal of Clinical Oncology · 5
A Novel Dietary Index for Gut Microbiota ( DI ‐ GM ) is Associated With Inflammation, Mental Health, and Tumor Biomarkers in Adults: A Cross‐Sectional Study
2025 · Yaqin Meng, Weiyu Ma, et al. · Food Science & Nutrition · 3
PDF
Efficacy and safety of XNW27011, a Claudin-18.2 targeted (CLDN18.2) ADC, in advanced pancreatic ductal adenocarcinoma: A phase 2 study.
2026 · Linlin Wang, Tianshu Liu, et al. · Journal of Clinical Oncology · 1
PDF
Tislelizumab plus chemoradiotherapy (CRT) versus CRT or chemotherapy (CT) as the neoadjuvant treatment for patients (pts) with locally advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A multicenter, randomized controlled, open-label, phase IIb study (TERRIFIC).
2026 · Jia Wei, Hongfeng Gou, et al. · Journal of Clinical Oncology · 1
PDF
The CONVERGE study: A phase II, single-arm trial of adebelimab combined with targeted therapy and liposomal irinotecan-based chemotherapy for conversion surgery in unresectable MSS colorectal cancer liver metastases.
2026 · Wenhui Yang, Haiyi Liu, et al. · Journal of Clinical Oncology
Corrigendum to “Injectable anticancer biodegradable hydrogel-based nanocomposites: Synergistic pH-responsive paclitaxel/β-cyclodextrin nanocomplex delivery in polyvinyl alcohol hydrogel for targeted pancreatic ductal adenocarcinoma treatment” [Int. J. Pharm. 677 (2025) 125514]
2025 · Xiuxiu Li, Weiyu Ma, et al. · International Journal of Pharmaceutics
Relationship between inflammatory response and radiotherapy in patients with advanced esophageal cancer
2020 · Yaqiong Ren, Ninggang Zhang, et al. · Zhongguo linchuang shiyong yixue
Adverse reactions of bevacizumab combined with chemotherapy in treatment of advanced colorectal cancer
2017 · Ninggang Zhang, Yusheng Wang, et al. · 药物不良反应杂志
メシル酸阿Pa替尼片による原発性肝癌の肺転移の1例を報告する。【JST・京大機械翻訳】
2016 · Ninggang Zhang, Yusheng Wang · Zhongliu fangzhi yanjiu
Apatinib Treatment for Primary Liver Cancer with Lung Metastasis: A Case Report
2016 · Ninggang Zhang, Yusheng Wang · Zhongliu fangzhi yanjiu
Efficacy and safety of bevacizumab plus chemotherapy in treatment of patients with metastatic colorectal cancer
2014 · Ninggang Zhang, Yusheng Wang, et al. · 肿瘤研究与临床
[Experimental study on co-culture of early embryo and cancer cells in vitro].
2009 · Ninggang Zhang, Xi Yan, et al. · PubMed
Works count: 20
Citation count: 138
H-index: 7
I10-index: 5
Year
Topic
Type